Total item
Cart Subtotal
$0.00 - Naomi Ito, .et al. miR-15b mediates oxaliplatin-induced chronic neuropathic pain through BACE1 down-regulation, Br J Pharmacol, 2017, Mar; 174(5): 386-395 PMID: 28012171
Biological Activity
LY2886721 is a novel potent agent that is used to treat Alzheimer's Disease in preclinical experiments.
Targets
| BACE | ||||
| In vitro | DMSO | 9 mg/mL (23.05 mM) | |
| Water | <1 mg/mL (<1 mM) | ||
| Ethanol | <1 mg/mL (<1 mM) | ||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 25.61 mL | 128.07 mL | 256.15 mL |
| 0.5 mM | 5.12 mL | 25.61 mL | 51.23 mL |
| 1 mM | 2.56 mL | 12.81 mL | 25.61 mL |
| 5 mM | 0.51 mL | 2.56 mL | 5.12 mL |
*The above data is based on the productmolecular weight 390.4 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Catalog Num | A10543 |
|---|---|
| Actions | Inhibitor |
| M. Wt | 390.4 |
| Formula | C18H16F2N4O2S |
| Solubility | DMSO |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 1262036-50-9 |
| Synonyms | LY-2886721 |
| SMILES | C1[[email protected]]2CSC(=N[[email protected]]2(CO1)C3=C(C=CC(=C3)NC(=O)C4=NC=C(C=C4)F)F)N |
Product Tags
Product Questions
Product Questions
No Questions
Keywords:buy LY2886721 | LY2886721 Supplier | purchase | cost | manufacturer | order | distributor | buy 1262036-50-9| 1262036-50-9 Supplier | purchase 1262036-50-9 | 1262036-50-9 cost | 1262036-50-9 manufacturer | order 1262036-50-9 | 1262036-50-9 distributor
Adooq Quality Guarantee
We promise all products perform as described.